Paxlovid update: Effectiveness, rebounding, drug interactions

One of our biggest public health challenges is to decrease the rate of severe COVID-19 disease in the face of pandemic fatigue, dried up funding, misinformation, and a changing virus. Paxlovid—an antiviral medication—is a tool we still have left.

However, recent data shows concerning trends of Paxlovid use. For example, less than 30% of 80-85 year-olds …